Clin2
NCT07680842Possibly a fitRecruiting

Non-invasive ultrasound for drug-resistant epilepsy

Drug-Resistant EpilepsyEpilepsyEpilepsy (Treatment Refractory)Epilepsy ComorbiditiesEpilepsy, Drug ResistantEpilepsy, GeneralizedEpilepsy, Focal

Part of Brain & nervous system clinical trials.

This study tests a non-invasive focused ultrasound treatment for people with epilepsy that doesn't respond to medications. The goal is to see if this gentle ultrasound can reduce seizures without surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
21 years to 65 years
Study type
Interventional

Who can take part

  • You are between 21 and 65 years old.
  • You have epilepsy that is not well controlled by medications and have at least 4 seizures per month.
  • You are willing to have a brain MRI scan and wear a headband during treatment.
  • You can keep a daily log of your seizures.
  • You have not had a craniotomy (skull surgery) or abnormal blood vessels in the brain in the treatment area.
  • You are not pregnant, breastfeeding, or planning pregnancy, and you do not have other serious neurological diseases like Alzheimer's or multiple sclerosis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06388707Recruiting· Phase 1/Phase 2
Ultrasound brain stimulation for drug-resistant epilepsy

This trial tests a low-intensity focused ultrasound device that aims to calm overactive brain areas causing seizures. It's for people whose seizures are not controlled by medication.

Palo Alto, California
NCT07249190Not yet recruiting· Phase 1
Ultrasound brain treatment for drug-resistant epilepsy

This trial tests a non-invasive procedure that uses MRI-guided ultrasound to treat a small area in the brain (the anterior nucleus of the thalamus) that is involved in seizures. It is for people with epilepsy that does not get better with medications.

NCT03868293Recruiting
Low-intensity ultrasound for drug-resistant temporal lobe seizures

This pilot study tests whether low-intensity focused ultrasound can reduce seizures in adults whose temporal lobe epilepsy hasn’t improved with at least two anti-seizure medicines. You may be asked to track seizure timing and undergo brain imaging before and during the study.

Boston, Massachusetts
NCT06492720Recruiting
Testing focused ultrasound for drug-resistant epilepsy

This study tests a new device called NaviFUS that uses focused sound waves to gently stimulate a small area of the brain. It is for people whose seizures start in one part of the brain and are not fully controlled by seizure medicines.

Taipei
NCT06292494Recruiting
Focused ultrasound for drug-resistant epilepsy

This trial tests whether focused ultrasound can help people whose seizures are not controlled by two or more medications. You would have a noninvasive procedure while awake, pressing a stop button if needed, and your hair will be partially shaved.

Taipei
NCT07353918Enrolling by invitation
Focused ultrasound for epilepsy treatment

This study tests if low-intensity focused ultrasound can calm overactive brain areas in people with epilepsy. It may offer a new way to reduce seizures without surgery or strong medications.

Roanoke, Virginia

Hear when a new Drug Resistant Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.